Problem

Heidi Health addresses the administrative overload that constrains clinical capacity: healthcare demand is rising while clinicians have less time available, creating pressure on wellbeing, patient safety, and the economics of care delivery. The central pain is that clinicians must spend substantial time converting consultations into documentation and then handling related evidence searches and follow-up communications rather than focusing on patients. The killer use case is ambient clinical documentation—capturing a consultation and turning it into a usable clinical record, helping return clinician time to care.

Product / Service

Heidi positions itself as an AI care partner that works alongside clinicians and automates tasks including clinical documentation, evidence search, and follow-up communications. Its Scribe product creates real-time clinical documentation from audio; Evidence supports clinical decision-making and literature lookup with citations; Remote provides an encrypted wearable microphone for offline ambient capture; and Comms supports clinical communications.

The product is also delivered through an integration layer: Heidi offers a public API and embeddable widget so EHR vendors, telehealth platforms, and other partners can place ambient documentation inside existing workflows. The claimed benefit is less administrative work and more usable clinical capacity, with integrations spanning systems such as Epic, Oracle Cerner, Athenahealth, Best Practice, Cliniko, and MediRecords.

Market

Heidi competes in the clinical AI and ambient AI medical-scribe market, with a broader position spanning clinical documentation, decision support, and communications. Abridge is identified as one comparable company, although the available evidence does not provide a complete competitor list. Heidi’s expansion from an ambient scribe into a broader AI care-partner platform suggests competition is increasingly based not only on transcription quality, but also on workflow integration, evidence capabilities, security, and breadth of clinical use cases.

Heidi is not pre-revenue. Company and third-party materials indicate substantial commercial traction: the platform is used by more than one million clinicians across 50-plus countries, while company materials report more than two million consults per week across 116 countries and 110 languages. An April 2026 report said annualized revenue had reached approximately US$50 million and that the company had raised about US$100 million, with a reported valuation of US$660 million.